Patent cliffs & loss of exclusivity
Tarsus Pharmaceuticals is developing innovative therapies for Demodex blepharitis and eye care.
| Company Operating Status | Active |
|---|---|
| Facebook URL | https://www.facebook.com/tarsusrx/ |
| Instagram URL | https://www.instagram.com/tarsusrx/ |
| LinkedIn URL | https://www.linkedin.com/company/tarsus-pharmaceuticals-inc |
| Pitchbook URL | https://pitchbook.com/profiles/company/339890-50 |
| Twitter URL | https://twitter.com/tarsusrx |
| Official Website | http://www.tarsusrx.com/ |
Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.